| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accurate accounting of caplacizumab cost effectiveness
|
Goshua, George
|
|
|
8 |
5 |
p. e315
|
artikel
|
| 2 |
Accurate accounting of caplacizumab cost effectiveness – Authors' reply
|
Hughes, Mary
|
|
|
8 |
5 |
p. e316
|
artikel
|
| 3 |
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
|
Risitano, Antonio M
|
|
|
8 |
5 |
p. e344-e354
|
artikel
|
| 4 |
A probable case of aggressive extranodal natural killer T-cell lymphoma in a 19th century Qing Dynasty painting
|
Fan, Bingwen Eugene
|
|
|
8 |
5 |
p. e321-e322
|
artikel
|
| 5 |
Chen Saijuan: from textile mill worker to haematologist
|
Kirby, Tony
|
|
|
8 |
5 |
p. 320
|
artikel
|
| 6 |
COVID-19 vaccines: building and maintaining confidence
|
The Lancet Haematology,
|
|
|
8 |
5 |
p. e305
|
artikel
|
| 7 |
COVID-19 vaccines for patients with haematological conditions
|
Sun, Clare
|
|
|
8 |
5 |
p. e312-e314
|
artikel
|
| 8 |
Factor B inhibition for paroxysmal nocturnal haemoglobinuria
|
Brodsky, Robert A
|
|
|
8 |
5 |
p. e309-e310
|
artikel
|
| 9 |
Ocular involvement in extranodal natural-killer T-cell lymphoma
|
Yang, Peizeng
|
|
|
8 |
5 |
p. e382
|
artikel
|
| 10 |
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study
|
Azoulay, Élie
|
|
|
8 |
5 |
p. e355-e364
|
artikel
|
| 11 |
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management
|
Zhao, Eric J
|
|
|
8 |
5 |
p. e365-e375
|
artikel
|
| 12 |
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
|
Biemond, Bart J
|
|
|
8 |
5 |
p. e334-e343
|
artikel
|
| 13 |
Sevuparin trial for acute pain in sickle cell disease: the dog that did not bark
|
Ellsworth, Patrick
|
|
|
8 |
5 |
p. e307-e309
|
artikel
|
| 14 |
Surviving the storm: critical care outcomes of chimeric antigen receptor T-cell therapy
|
Athale, Janhavi
|
|
|
8 |
5 |
p. e311-e312
|
artikel
|
| 15 |
47th Annual Meeting of the EBMT
|
del Pozo Martín, Yaiza
|
|
|
8 |
5 |
p. e317-e318
|
artikel
|
| 16 |
The changing face of haemophilia care in Pakistan
|
Tariq, Rabbia
|
|
|
8 |
5 |
p. e319
|
artikel
|
| 17 |
The power of specialty palliative care: moving towards a systems perspective
|
Barnato, Amber E
|
|
|
8 |
5 |
p. e376-e381
|
artikel
|
| 18 |
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial
|
Howard, Jo
|
|
|
8 |
5 |
p. e323-e333
|
artikel
|
| 19 |
Will the changing therapeutic landscape meet the needs of patients with sickle cell disease?
|
Inusa, Baba Psalm Duniya
|
|
|
8 |
5 |
p. e306-e307
|
artikel
|
Tijdschrift beschrijving